Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Fluids Barriers CNS 16 , 1 (2019)
investigation 120 (11), 40074020
Semaglutide is primarily prescribed for individuals with type 2 diabetes who have not achieved adequate blood sugar control with diet and exercise alone
Cost-effectiveness: what patients say about value Patient reviews that mention cost reveal a value-perception threshold: At $25-35 per injection ($100-140 monthly): 81% of patients reporting subjective benefit rate the injections as "worth the cost." At $40-50 per injection ($160-200 monthly): 62% rate as "worth the cost." At $55+ per injection ($220+ monthly): 43% rate as "worth the cost." The value perception correlates with magnitude of benefit
This is one of the most unique features of retatrutide and may play a significant role in its weight loss effects
The withdrawal reflected commercial considerations rather than safety concerns
US$ 26.39
US$ 28.73
US$ 29.65
US$ 27.86
